LIVDELZI
Live / Registered — Registered (as of 12 May 2026)
What this means for you
Registered since 12 May 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 May 2032: the §8 declaration of use).
Record
- Serial number
- 98517068
- Registration number
- 8255195
- Mark type
- Design + words
- Filed
- 24 Apr 2024
- Published for opposition
- 17 Dec 2024
- Registered
- 12 May 2026
- Next maintenance filing
- §8 declaration of use, due by 12 May 2032 (grace period to 12 Nov 2032)
- Attorney of record
- Shelley Lai
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical preparations for treatment of inflammatory diseases and disorders; pharmaceutical preparations for treatment of fibrosis
Owner
- CymaBay Therapeutics, Inc., Foster City, CA, US
- CymaBay Therapeutics, Inc., Foster City, CA, US
- CymaBay Therapeutics, Inc., Newark, CA, US
Prosecution history
- 12 May 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 May 2026 — REGISTERED-PRINCIPAL REGISTER
- 17 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Jul 2025 — USE AMENDMENT FILED
- 13 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 30 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED